Skip to main content

Table 1 Clinical characteristics of skin donors at DCCT baseline and mean AGE levels at time of DCCT biopsy

From: Skin collagen advanced glycation endproducts (AGEs) and the long-term progression of sub-clinical cardiovascular disease in type 1 diabetes

 

Primary

Secondary

P value

N = 216

123

93

 

DCCT baseline

 Female (%)

53 %

41 %

 

 Age (years)

27.1 (6.8)

29.6 (6.5)

0.009

 Duration (months)

2.7 (1.4)

8.6 (4)

<0.001

 HbA1c (%) (mmol/mol)

9.1 (1.8)

8.9 (1.5)

 

 Mean blood glucose (mg/dl)

230.4 (82.8)

225.6 (71.5)

 

 Triglycerides (mg/dl)

72.4 (50.5)

92.9 (51.6)

<0.001

 Cholesterol (mg/dl)

178.3 (32.7)

179.1 (36.5)

0.006

 Retinopathy (%)

   

  10/10: None

100

0

 

  20/≤20: Microaneurysms only

0

60

 

  30/≤30: Mild NPDR

0

28

 

  45/≤45: Moderate NPDR

0

11

 

 AER >40 mg/24 h

1

10

0.003

 Confirmed clinical neuropathy (%)

3

14

0.004

 sBP (mmHg)

114.7 (11.9)

119.4 (10.5)

 

 dBP (mmHg)

72.9 (8.5)

75.1 (7.8)

 

AGEs and solubility parameters

 Acid soluble (%)

0.5 (0.3)

0.6 (0.4)

 

 CEL (pmol/mg collagen)

141.4 (104)

152.5 (111.1)

 

 CML (pmol/mg collagen)

527.8 (140.4)

548.1 (119.2)

 

 Furosine (pmol/mg collagen)

756.2 (239.9)

786.2 (219.8)

 

 G-H1 (pmol/mg collagen)

66.8 (30.7)

63.6 (38)

 

 GSPNE (nmol/mg collagen)

2.5 (0.6)

2.6 (0.7)

 

 MG-H1 (nmol/mg collagen)

0.8 (0.4)

0.8 (0.5)

 

 Pentosidine (pmol/mg collagen)

25.3 (6.2)

26.6 (8.6)

 

 Pepsin Soluble (%)

6.8 (3.5)

6.5 (3)

Â